Czechia· CZ-0002917
MULTIHANCE
A gadobensäure product containing gadobenate dimeglumine, registered in Czechia by Bracco Imaging Deutschland GmbH, Konstanz. The same ATC class is registered in 9 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Gadobensäure is registered in 9 of 19 countries.
Countries holding a registration under ATC V08CA08 (gadobensäure), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 5 of them publish a price we can compare per daily dose
Gadobensäure · ATC V08CA08
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- GADOBENATE DIMEGLUMINE
- Manufacturer
- Bracco Imaging Deutschland GmbH, Konstanz
- Country
- Czechia (CZ)
- ATC code
- V08CA08
- ATC class
- Gadobensäure
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadobensäure in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumMultihance 529 mg/mlBracco Imaging Deutschland
- United KingdomMultiHance 0.5mmol/ml solution for injection 10ml vialsBracco UK Ltd
- IrelandMultiHance 529 mg/ml solution for injection in pre-filled syringeBracco Imaging spa
- FranceMULTIHANCE 0,5 mmol/mL, solution injectable (IV)BRACCO IMAGING FRANCE
- SwedenMultiHance 334 mg/ml Injektionsvätska, lösningBracco Imaging SpA
- United StatesMultiHanceBRACCO DIAGNOSTICS INC
- GermanyMultihanceBracco Imaging Deutschland Gmbh
- CanadaMULTIHANCEBRACCO IMAGING CANADA
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Multihance
- Belgium · Multihance
- Germany · Multihance
- Denmark · Multihance
- Spain · Multihance
- Finland · Multihance
- France · Multihance
- United Kingdom (Northern Ireland) · Multihance
- Greece · Multihance
- Croatia · Multihance
- Hungary · Multihance
- Ireland · Multihance
- Italy · Multihance
- Luxembourg · Multihance
- Netherlands · Multihance
- Norway · Multihance
- Poland · Multihance
- Portugal · Multihance
- Romania · Multihance
- Sweden · Multihance
- Slovenia · Multihance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5d554322-e6b9-455e-bc1f-fa9f48218f61 GET /v1/drugs/5d554322-e6b9-455e-bc1f-fa9f48218f61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ SOL",
"source": "sukl",
"strength": "529MG/ML",
"pack_size": "1X5ML",
"substance": "GADOBENATE DIMEGLUMINE",
"cz_kod_sukl": "0002917",
"product_type": "CH",
"substance_codes": "15973",
"registration_state": "R",
"registration_number": "48/495/00-C"
}See everything about gadobensäure.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.